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The ketogenic diet is a trending diet garnering much attention and interest. But do people 
know what it is, how it works, and where it came from? The ketogenic diet is a high-fat, 
low-carbohydrate diet that was originally created to treat childhood epilepsy but has been 
found useful for many other things. Because of its low carbohydrate allowance, the body 
is deprived of glucose, its main fuel source, and instead burns stored fat into ketone 
bodies for energy. This process of ketosis promotes weight loss in a highly controversial 
way and can implicate unhealthy consequences. Ketosis can quickly worsen into 
ketoacidosis, a life-threatening condition that dangerously lowers the pH of the blood. In 
addition, the ketogenic diet’s recommended high fat intake can increase LDL cholesterol 
levels, which can quickly become detrimental to health. Not only this, it may promote 
rapid weight loss in a short period of time, but does not guarantee that weight loss will be 
sustained. Several articles are under examination to determine the ketogenic diet’s 
efficacy and if it is trending for all the right or wrong reasons. Low-carbohydrate 
(ketogenic) diets and low-fat diets are compared in numerous studies and ways, including 
weight loss results, cholesterol and lipid levels, but somehow inconsistent results prevail. 
Through the use of randomized control trials, case reports, and several systematic reviews 
with meta-analyses, the ketogenic diet’s history, worldwide prevalence, and uses beyond 
weight loss, including treatment of certain cancers, are brought to light in a way that 
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What is the ketogenic diet? 
The ketogenic diet is by nature a high-fat, low-carbohydrate, low-protein diet. The 
extremely limited consumption of carbohydrates significantly reduces the levels of 
glucose in the body. Glucose is the primary source of fuel for most tissues in the body so 
when it becomes unavailable, the body begins to break down its fat stores into ketone 
bodies to be used as an alternate source of energy. This process is known as ketosis and if 
prolonged, can result in ketoacidosis, which occurs when the body continues to break 
down fat into ketone bodies at an even faster rate. During ketoacidosis, the numerous 
amounts of ketones circulating in the body can lower the pH of blood to a dangerous 
level.  Ketoacidosis is a life-threatening condition that can quickly lead to death if not 
treated. The biological effects of the ketogenic diet mimic what happens in the body 
when fasting or even starvation occurs. Individuals who undergo starvation/fasting and 
individuals who consume a ketogenic diet all enter this state of ketosis.  
 
History of the Ketogenic Diet 
The ketogenic diet was developed in the 1920s as a way to treat epilepsy in children 
(Stafstrom & Rho, 2004). Originally, fasting was used to treat seizures because anecdotal 
evidence at that point suggested that complete abstinence from food and drink provided a 
cure. However, this practice was found to be more successful in children than in adults 
(Conklin, 1922). The makeup of the ketogenic diet was first proposed as one gram of 
protein per kilogram of body weight (in children), 10-15 grams of carbohydrates per day, 
and the remainder of calories designated to fat (Stafstrom & Rho, 2004). This distribution 
is identical to the ketogenic diet that is in practice today. When following this diet, 
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significant improvements in behavior and cognitive effects were reported along with 
reduction of seizures (Peterman, 1925). The resulting successes created extensive interest 
in the ketogenic diet, as there have been many studies done that evaluate changes in 
mood, behavior, and cognitive skills (in addition to the reduction of seizures) when 
following the ketogenic diet.  
 
Use of the Ketogenic Diet in Childhood Epilepsy  
Because of the early potential exhibited by the ketogenic diet in treating childhood 
epilepsy, a systematic review was conducted to determine the effectiveness of the 
ketogenic diet as a treatment for childhood epilepsy (Keene, 2006). The inclusion criteria 
of studies consisted of the following: written in English or French, completed after 1990, 
and patients 18 years old or younger with diagnosed refractory epilepsy, which is defined 
as ineffectual control of seizures despite use of multiple antiepileptic medications. The 
authors considered the outcomes in a time period of 6 months where the key outcome 
measured was the change in seizure frequency, where 100% would be complete cessation 
of seizures and seizure reduction of 50% or greater was considered a “significant 
decrease.” With these criteria, a total of 26 studies were included, which provided a total 
patient population of 972. All individuals had previously used antiepileptic medication 
without a significant decrease in seizures. Each study was then categorized as either class 
one, two, or three evidence. Class one was defined as including a prospective-controlled 
study with well-defined cohort, adequate sample size, blinded interpretation of outcome, 
and presence of a description of method analysis. Unfortunately, none of the 26 studies 
were classified as class one. Class two evidence was defined as either being an 
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uncontrolled prospective study or a retrospective study that had well-defined cohort, an 
adequate sample size, blinded interruption of outcome, and a description of method 
analysis. Fifteen of the studies were considered to be class two. Any study that did not 
meet these standards was considered to be class three. Only the studies that qualified as 
class two were included in the analysis of the efficacy of the diet, and are shown below in 
Table 1 from the article. 
Table 1. Description of studies using the ketogenic diet as a treatment for childhood 
epilepsy (Keene, 2006) 
 
Unfortunately, the remaining studies were only used in the analysis of adverse effects of 
the ketogenic diet, which are not under examination in this case.  At the end of the 6-
month time period, 15.6% of the total patients had 100% cessation of seizures while 
33.0% had a seizure reduction of 50% or more. This study did show successes of the 
ketogenic diet treating childhood epilepsy but still left many questions unanswered, such 
as: Which type of patient would the ketogenic diet benefit most? What is the necessary or 
optimal duration of following the ketogenic diet to yield benefits with regard to epilepsy? 
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Which patient is at risk of an adverse event? Is there a cost/benefit of the diet? The 
authors concluded that more research needs to be conducted, but because of the large 
range of antiepileptic medications available today, the ketogenic diet is uncommonly 
used as an exclusive treatment for epilepsy and therefore less time and attention is 
devoted to answering these questions. 
 
Worldwide Use of the Ketogenic Diet  
Since epilepsy is a somewhat prevalent condition (affecting about 100 million people 
worldwide) in all races and cultures, The Johns Hopkins Medical Institutions conducted a 
worldwide survey-based study in 2005 to evaluate the use of the ketogenic diet 
worldwide (Kossoff & Mcgrogan, 2005). Unfortunately, many countries cannot afford or 
do not have access to anticonvulsant drugs as a treatment for epilepsy so the ketogenic 
diet is their best option. The investigators contacted international ketogenic diet centers 
via email for information regarding patient enrollment, year the diet was first offered, 
unique cultural and religious issues in the country, community opinion, and research 
interests. After receiving responses, they had collected full historical information about 
the ketogenic diet in 73 centers in 41 different countries (outside of the United States). 
While the types of foods consumed in each country varied, they all successfully followed 
the proper ketogenic diet ratio. Although the exact number of people using the ketogenic 
diet as a treatment for epilepsy is unknown, it is considered to be a highly utilized diet 
worldwide. The map below, Figure 1, taken from this article, shows which countries have 










Figure 1. Countries providing the ketogenic diet highlighted in gray (Kossoff & 
Mcgrogan, 2005) 
 
Ketogenic Diet as a Treatment for Brain Cancer  
For the past 30 years, the ketogenic diet has been under investigation to determine if it is 
a possible treatment for brain cancer – specifically for glioblastomas, which are 
extremely aggressive tumors that develop in the brain. Because many tumors depend on 
glucose for development and survival, it has been proposed that the lack of glucose 
consumed during the ketogenic diet can inhibit the growth of tumors (Schwartz, Noel, 
Nikolai, & Chang, 2018). Several studies have been conducted that assess the effects of 
the ketogenic diet on tumor cell growth and survival, both in humans and in animals. A 
randomized control trial tested both in vitro and in vivo models to determine if ketone 
bodies decrease tumor cell viability and prolong survival time of mice with metastatic 
cancer (Poff, Ari, Arnol, Seyfried, & Dagostino, 2014). The in vitro model used VM-
M3/Fluc cells, which are known to progress and metastasize in an extremely similar 
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manner to that of metastatic cancers. These cells were extracted from a spontaneous brain 
tumor that developed in VM/Dk inbred mice. These cells were plated into one of four 
groups: high or low glucose media with or without ketone supplementation. The authors 
found that low glucose, ketone supplemented cells had the slowest cell proliferation rate 
and the greatest percent of cell viability (close to 100%) in contrast to the high glucose, 
non-supplemented group that had the fastest cell proliferation rate and the smallest 
percent of cell viability (close to 75%). The data results in Figure 2 are shown below, 







Figure 2. In vitro cell proliferation and viability data (Poff, Ari, Arnol, Seyfried, & 
Dagostino, 2014)  
 
The in vivo model included 36 adult male VM/Dk mice that were all implanted with VM-
M3/Fluc (cancer) cells and were assigned to 4 different groups: standard diet, calorie 
restricted, 1,3-butanediol (a type of ketone body), or ketone ester. They found that the 
bioluminescence scan of all mice did not show significantly different tumor changes. 
However, the mice supplemented with ketones demonstrated a significantly prolonged 
survival time compared to the control mice; the mice supplemented with ketone esters 
showed the greatest increase in mean survival time. The data results in Table 2 are shown 











Table 2. In vivo survival time data; *p < 0.05; ***p < 0.001 (Poff, Ari, Arnol, Seyfried, 
& Dagostino, 2014) 
 
There have been several similar studies conducted which led to the creation of a 
systematic review that was able to include 13 studies (Miraghajani, et al., 2017). The sole 
inclusion criterion was that a study had to be an experimental study on animals that 
reported effects of the ketogenic diet (as the only treatment) on tumor cells growth rate 
and survival time. Table 3 below was taken from this systematic review describing all 13 
studies that were used including the first author, country, year, animal model, cancer 





Table 3. Summary of studies included in the systematic Review (Miraghajani, et al., 
2017) 
 
Of the 13 studies included, all concluded that the ketogenic diet had an inhibitory effect 
on tumor growth and 9 included evidence indicating that the ketogenic diet inhibited 
tumor growth and even prolonged survival time of the animals. Because this is a 
systematic review, it was not limited solely to glioblastomas but also to pancreatic, 
prostate, gastric, colon, and lung cancers. These studies vary greatly in animal 
physiology, tumor make-up, ketogenic diet components/ratio/administration, and living 
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conditions. However, these studies exclusively utilize animal models and therefore it 
cannot be definitively concluded that these results would transfer to humans.  
In this context, a study was performed to see whether humans, particularly children in 
this case, would have the same successes with the ketogenic diet (Nebeling & Lerner, 
1995). A sample of pediatric patients with advanced-staged cancer were given a 
ketogenic diet that consisted of 60% medium-chain triglyceride oil, 20% protein, 10% 
carbohydrate, and 10% other dietary fats to test the effects on tumor glucose metabolism 
in an 8-week time period. They assessed changes in tumors through PET scans and found 
an average 21.8% decline in glucose uptake at the tumor sites.  
Following this study, a systematic review was written that investigated the role of 
ketogenic diets on adult and pediatric gliomas (Martin-Mcgill, et al., 2018). However, 
they were unable to find any randomized control trials and instead used six case reports, 
totaling 39 patients total. They found that all studies reported overall “progression-free 
survival”, but because they were case studies, the effectiveness of the ketogenic diet as a 
treatment for gliomas in humans could not be established. They stated that the 
acceptability of the ketogenic diet is unknown and that randomized control trials need to 
be conducted.  
 
What is the ketogenic diet used for now?  
Although developed as a therapy for epilepsy, the ketogenic diet is now widely used as a 
weight loss and weight maintenance diet. However, because of its discordance with 
standard dietary guidelines that state an adult should consume 130 grams of 
carbohydrates a day and consume only 20-35% of daily caloric intake from fats (U.S. 
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Department of Health and Human Services and U.S. Department of Agriculture, 2015) it 
leaves many people skeptical about its safety and effectiveness. Its prevalence has 
triggered the exploration of the diet’s mechanisms and efficacy in promoting weight loss. 
However, there are still many gaps in the evidence, as some studies strongly support the 
diet and some do not find it any more beneficial in promoting weight loss than a standard 
low-fat diet. It is proposed that while following the ketogenic diet, weight loss is 
achieved through a combination of factors including the satiating effect of protein, 
increased energy expenditure, appetite suppression from ketosis, increased bound-water 
loss, and food choice restriction (Malik & Hu, 2007). However, many argue that the 
weight loss during the ketogenic diet primarily results from water loss and food choice 
restriction, not just from ketosis. One of the biggest criticisms of the ketogenic diet is that 
it can be used as a way to initially lose weight, but is not an effective way to promote 
sustained weight loss. Numerous studies have been conducted comparing the weight loss 
results of low-carbohydrate diets (ketogenic) versus low-fat diets. 
After evaluating several randomized control trials, the results remain inconsistent. 
However, there are many study samples and design factors to consider that may cause 
discordant results among studies, such as such as: BMI, age group, sex, duration of diet, 
chronic disease prevalence, physical activity level, and adherence to diet. One 
randomized control trial assessed the differences in a low-carbohydrate ketogenic versus 
a low-fat diet in severe obesity and found that in a 6-month period, the low-carbohydrate 
ketogenic diet group achieved greater weight loss (Samaha, et al., 2003). However, after 
one year the authors found that there were no longer significant differences in weight loss 
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Figure 3. Data showing weight loss differences between low-carbohydrate ketogenic diet 
and low-fat diet in severe obesity (Stockman, 2006). 
 
A systematic review with meta-analysis, examined 13 studies, which included a total of 
1577 individuals, that compared the differences in weight loss between a very-low-
carbohydrate ketogenic diet and a low-fat diet (Bueno, Melo, Oliveira, & Ataide, 2013). 
Each individual was randomly assigned to a group, very-low-carbohydrate diet (790 
individuals) or low-fat diet (787 individuals). A very-low-carbohydrate-diet was defined 
as the consumption of less than 50 grams of carbohydrates per day or 10% of daily 
energy from carbohydrates and a low-fat diet was defined as a restricted-energy diet with 
less than 30% of daily energy from fat. The participants in these studies were assigned to 
the respective diets to assess potential changes in body weight and key risk factors. Table 
4 below, taken from the article, includes key information of all 13 studies including 
duration of diet, amount of dietary counseling, number of dropouts, percentage of 
females, country, risk factor, mean age, mean BMI, and carbohydrate intake. 
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Table 4. Systematic review study descriptions comparing very-low-carbohydrate 
ketogenic diets and low-fat diets (Bueno, Melo, Oliveira, & Ataide, 2013). 
 
This systematic review analyzed several aspects of the studies including body weight, 
LDL and HDL cholesterol, and blood triglyceride levels. They determined that the 
individuals assigned to the very-low-carbohydrate (ketogenic) diet achieved greater 
weight loss and reduction in triglyceride levels compared to the individuals assigned to 
the low-fat diet. The mean differences in weight loss are shown below in Figure 4, taken 













Figure 4. Data comparing weight loss between very-low-carbohydrate ketogenic diet and 
low-fat diet (Bueno, Melo, Oliveira, & Ataide, 2013). 
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However, the individuals in the very-low-carbohydrate ketogenic diet group also 
exhibited increases in HDL and LDL. They also found that the loss of body weight from 
a very-low-carbohydrate ketogenic diet can be the result of the increase in resting energy 
expenditure. This article concluded that very-low-carbohydrate ketogenic diets promote 
greater weight loss than low-fat diets and that ketogenic diets like these are an effective 
way to reduce obesity (and the risk of chronic diseases associated with obesity). 
However, these apparent benefits of a very-low-carbohydrate ketogenic diet should be 
weighed against evidence from this study suggesting a rise in LDL cholesterol, as it could 
be detrimental to one’s health.  
A second meta-analysis investigated several similar studies that compared weight loss 
results between low-carbohydrate and low-fat diets, but arrived at a different conclusion 
(Nordmann, et al., 2006). This study was comprised of five randomized control trails that 
included a total of 447 individuals. Like the previous study, each individual was 
randomly assigned to a group: very-low-carbohydrate diet (222 individuals) or low-fat 
diet (225 individuals). There are some discrepancies with the way low-fat diets were 
defined in each study; one study considered low-fat to include a maximum of 10% of 
daily energy to come from fat intake whereas the other 4 allowed a maximum of 30%. 
While this does not necessarily make a great difference in the data, it should be 
considered when evaluating the results. The data obtained indicated that greater weight 
loss was achieved in the low-carbohydrate diet groups in a 6-month period. However, at 
the 12-month mark, there was no significant difference in weight loss between the low-




Figure 5. Forest plot showing weighted mean differences between low carb and low-fat 
diets (Nordmann, et al., 2006) 
 
Though this was different than the previous systematic review, the results were similar 
pertaining to triglyceride, HDL and LDL cholesterol levels (meaning the low-
carbohydrate groups had a decrease in triglyceride levels but an increase in both HDL 
and LDL cholesterol levels). Because there were no differences in weight loss between 
the low-fat and low-carbohydrate groups, along with the increase in LDL cholesterol 
levels in the low-carbohydrate group, this study did not find strong evidence to 
recommend a low-carbohydrate diet as a means for weight loss or risk reduction.  They 
concluded that each diet is as effective as the other, but the changes in total cholesterol 
need to be taken into consideration when choosing a diet to follow.  
When considering the different findings from these two systematic reviews, it is 
important to consider the differences in each study and what potentially led to these 
discordant findings. The first systematic review with meta-analysis concluded that a very-
low-carbohydrate ketogenic diet yielded greater weight loss than the low-fat diet, 
however some things come to light when looking closer. Their study had greater dropout 
rates than the second systematic review with meta-analysis and they stated in the 
conclusion that very-low-carbohydrate ketogenic diets produce greater weight loss results 
was consistent with all studies except for the studies that had 24-month follow ups. They 
go further to mention that the weight-loss differences they observed long-term appear to 
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be of little clinical significance, although statistically significant. This appears to be more 
in line with what the second systematic review with meta-analysis concluded and agrees 
with the criticism that the ketogenic diet can be used as a way to initially lose weight, but 
is not an effective way to promote sustained weight loss.   
 
Discussion 
The ketogenic diet is a relevant and impactful diet in nutritional sciences today. Many 
people are unaware of where this trending diet came from, how it was created, and how it 
became so popular. Evidence shows that it has been successful in treating childhood 
epilepsy, but whether or not it is a viable treatment for certain tumors and for weight loss 
is still in question. Clinical trials are currently being conducted to investigate the 
ketogenic diet as a treatment for brain cancers (recurrent/refractory brain tumors) and are 
scheduled to be completed around November 2023. Hopefully such investigations will be 
able to give answers to some of the unanswered questions many have about the ketogenic 
diet’s efficacy when treating cancer. With regard to the ketogenic diet as a means for 
weight loss, long-term studies (5-10 years) need to be conducted to discover if weight 
loss is continued/maintained and if cholesterol levels continue to increase. Many people 
do not consider the long-term effects that certain exposures have on the body, but just 
immediate results.  It is imperative to understand exactly what a diet could do to the 
body, helpful or harmful, in a long-term perspective. There are many other ideas and 
myths about the ketogenic diet and what positive effects it can have on the body, but 
because of the negatives that are unable to be ignored, I would not recommend the 
ketogenic diet as a weight loss solution.  
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